Pharmacovigilance Europe Congress 2020 | Annual International Conference and Exhibition in Drug Safety, Regulatory Affairs, Risk Management and Clinical Tests

Speaker Details

Dr Stephanie Millican

Medicines and Healthcare products Regulatory Agency
Unit Manager VRMM | MHRA

Dr Stephanie Millican joined the MHRA in 1996 following a career in academia. Following various assessor roles within the Post-Licensing area of Agency, she became manager of the Post-authorisation Signal Unit, part of the Vigilance and Risk Management of Medicines Division (VRMM), in April 2011 and is now based within the Benefit Risk Management Group (VRMM). Her team has responsibility for the assessment of the majority of Type II safety–related variations and she therefore has a keen interest in process improvements in this area.

View Speaker Video